Anchiano stock: buy or sell?
December 6th, 2019
Should I buy Anchiano stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Having a trading strategy helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Anchiano stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Anchiano stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we detected 2 ratings published for ANCN stock in the last 30 days.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-3-11||LADENBURG THALM/SH SH||n/a||Buy|
Anchiano stock analysis
Anchiano shares depreciated -1.24% to $1.59 on Dec 6th.
Shares of Anchiano Therapeutics depreciated an ugly -1.24% and closed at $1.59.
Anchiano Therapeutics shares rocketed 12.77% this week, ending at $1.59. By mid November ANCN plunged a bloodcurdling -40.15% in just one week.
Since price and 10-weeks moving average lines crossed down by mid November, ANCN fell $-0.78 per share (-32.91%). Far behind is the all-time high Anchiano Therapeutics recorded by mid February and since then the price is -86.17% below that top.
Anchiano stock price history
Anchiano IPO was on February at $11.50 per share1. Since then, ANCN stock declined a -86.20%, with a yearly average of inf%.
1: Adjusted price after possible price splits or reverse-splits.
Anchiano stock historical price chart
ANCN stock reached all-time highs on February with a price of $11.50.
Anchiano stock price target is $16.00Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' ANCN stock price predictions in the hope that they will be met as they may be wrong and not met. Currently, only 1 price forecast for Anchiano Therapeutics stock was published in the last 30 days:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
Financials and fundamental analysis
Earnings date and Earnings per Share
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Anchiano ownershipWhen you are planning to buy shares of a stock, it's worth to review its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Anchiano, 23.87% of all outstanding shares are owned by its staff.
In case of Anchiano Therapeutics stock, 0.75% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ANCN stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$11.8 M|
|Total shares||7.4 M|
|Float shares||3.3 M|
|- Institutional holdings (%)||0.8%|
|- Insider holdings (%)||23.9%|
|Shares in short selling||0.0%|
|Friday, December 6th, 2019|
|Day range||$1.58 - $1.83|
|Average true range||$0.23|
|50d mov avg||$2.05|
|100d mov avg||$2.50|
|200d mov avg||$0.00|
Anchiano performanceTo better understand Anchiano Therapeutics performance you must becnhmark its gains with other related stocks in same sector or industry. In the following table, we compare Anchiano Therapeutics to :